A randomised, double-blind, placebo-controlled, multicentre study of the safety and efficacy of BIOBYPASS (AdGVVEGF121.10NH) gene therapy in patients with refractory advanced coronary artery disease: The NOVA trial

Journal article published in 2011 by Jens Kastrup, Erik Jørgensen, Shmuel Fuchs, Sigrid Nikol, Hans Erik Bøtker

, Mariann Gyöngyösi, Dietmar Glogar, Ran Kornowski

This paper is available in a repository.

Full text: Download

Preprint: policy unknown

Upload

Postprint: policy unknown

Upload

Published version: policy unknown

Upload

Policy details

Data provided by